Covington Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Covington Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-40	Closed	-$2K	–	799
2017 Q4	$2K	Hold	40	–	–	﹤0.01%	788
2017 Q3	$2K	Buy	+40	New	+$2.34K	﹤0.01%	693

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Covington Capital Management's BIVV Position: Q1 2018 in Review

Covington Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 40 shares — an estimated $2K sold.

Covington Capital Management first reported a position in BIVV in Q3 2017 and held it in 2 quarters. The position peaked at $2K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Covington Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Covington Capital Management sold 40 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $2K.
Covington Capital Management first reported a position in Bioverativ Inc. Common Stock in Q3 2017 and held it in 2 quarters.
Covington Capital Management's Bioverativ Inc. Common Stock position peaked at $2K in Q4 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Covington Capital Management's 13F filing for Q1 2018, filed 11 May 2018.